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THIS SUBJECT
￿ Recruitment is key to the success of clinical
trials.
￿ Many clinical trials fail to achieve adequate
recruitment.
￿ Public understanding and engagement in
clinical research could be improved.
WHAT THIS STUDY ADDS
￿ ‘Get Randomised’is the ﬁrst campaign of its
kind in the UK.
￿ It is possible to improve public awareness of
clinical research using the media.
￿ Further work is needed to determine
whether improved public awareness leads
to increased participation in clinical research
in the future.
AIM
To increase public awareness and understanding of clinical research in
Scotland.
METHODS
A generic media campaign to raise public awareness of clinical
research was launched in 2008.The‘Get Randomised’campaign was a
Scotland-wide initiative led by the University of Dundee in
collaboration with other Scottish universities.Television,radio and
newspaper advertising showed leading clinical researchers,general
practitioners and patients informing the public about the importance
of randomised clinical trials (RCTs).‘Get Randomised’was the central
message and interested individuals were directed to the
http://www.getrandomised.org website for more information.To assess
the impact of the campaign,cross-sectional surveys were conducted in
representative samples of 1040 adults in Scotland prior to campaign
launch and again 6 months later.
RESULTS
There was an improvement in public awareness of clinical trials
following the campaign;56.7% [95% conﬁdence interval (CI) 51.8,61.6]
of the sample recalled seeing or hearing advertising about RCTs
following the campaign compared with 14.8% (10.8,18.9) prior to the
campaign launch (difference = 41.4%;95% CI for difference 35.6,48.3;
P < 0.01).Of those who recalled the advertising,49% felt that the main
message was that people should take part more in medical research.
However,on whether they would personally take part in a clinical trial
if asked,there was little difference in response following the campaign
[‘yes’31.3% (28.4,34.1) prior;30.4% (27.6,33.2) following;difference =
-0.9%;95% CI for difference -4.8,3.1%;P = 0.92].
CONCLUSIONS
It is possible to raise public awareness of clinical research using the
media,but further efforts may be required to inﬂuence individuals’
decisions to take part in clinical research.
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Clinical trials rely on adequate recruitment in order to
achieve their clinical and scientiﬁc aims.However,a recent
review of recruitment into UK trials showed that less that
one-third of trials recruited to target within the originally
speciﬁed time period and around one-third required
extensions to allow adequate recruitment [1]. A similar
picture of poor recruitment was found in a survey of UK
primarycaretrials[2].Failuretoachieverecruitmentwithin
a reasonable time period adds expense and logistical dif-
ﬁculties to clinical research and may result in failure to
answer the question that the trial was originally designed
to address.Also,poor recruitment delays the availability of
the results of the trial to inform clinical practice decisions.
Although many different factors interplay to determine
the level of recruitment into any one clinical trial, a key
factor is the initial engagement of potential patient
recruits to consider participation in the trial.
Current public understanding of clinical research is
poor and media coverage of clinical research trials is often
negative [3].With the aim of increasing public awareness
andunderstandingofclinicalresearchinScotlandandulti-
mately increasing public engagement in clinical trials, we
launched a generic media campaign in August 2008—the
‘GetRandomised’campaign(Figure 1).ThiswasaScotland-
wide initiative led by the University of Dundee in collabo-
ration with the Universities of Aberdeen, Edinburgh and
Glasgow. Television, radio and newspaper advertising
showed leading clinical researchers, general practitioners
and patients informing the public about the importance
of randomised clinical trials (RCTs). Interested individuals
were directed to a dedicated website (http://www.
getrandomised.org) to obtain more information.
In order to assess the impact of the ‘Get Randomised’
campaign on public awareness of clinical research in Scot-
land,asurveywasconductedintheScottishgeneralpublic
prior to the campaign launch and again after 6 months.
Participants were asked questions about their views on
andknowledgeofRCTsandclinicalresearch,whetherthey
had seen any recent advertising about clinical trials and
how the advertising had inﬂuenced them.
Methods
The ‘Get Randomised’ campaign was designed and initi-
ated by investigators at the University of Dundee. The
generic campaign was not linked to any particular
research study but rather aimed to increase general public
awareness of clinical research in Scotland.The content of
the campaign was reviewed by the Scottish Research
Ethics committee and was judged not to require formal
ethical approval.Television,radio and newspaper advertis-
ing were used in the campaign.Television advertisements
including leading researchers, general practitioners and
patients talking about clinical research were shown on
ScottishTelevision (Figure 2).Advertisements were region-
alizedwithfourdifferentversionstoincludelocalresearch-
ers and patients. Advertisements were mainly 30 s in
duration but some shorter versions lasting 10 s were also
included. Around 200 television advertisements were
broadcast over a 3-month period. Audio recordings with
similar content were played on local and national Scottish
radiostationsandadvertisementswereplacedinlocaland
national Scottish newspapers (Figure 3).The campaign ran
for 3 months and the initial budget for the production and
airtime of the television advertisements was £80 000.
Broadcoverageofthewholeadultpopulationwastheaim
of the campaign.
A‘GetRandomised’website,http://www.getrandomised.
org, was established to allow interested individuals to
access further information about clinical research and trial
design(Figure 4).Thewebsiteincludeslinkstootheruseful
websiteswithinformationonclinicalresearch.Examplesof
the advertisements are available to view on the website.
Figure 1
The logo for the‘Get Randomised’campaign was designed to depict the
message that people of all ages can participate in clinical research
Figure 2
Television advertising included leading researchers,general practitioners
and patients talking about the importance of clinical research. Here, Dr
Alex Watson (General Practitioner,Westgate Health Centre, Dundee, UK)
explains the importance of randomised clinical trials
Impact of‘Get Randomised’campaign
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Newspaper advertisements directed readers to the website for more information
Figure 4
The‘Get Randomised’website http://www.getrandomised.org contains information about randomised clinical trials and links to other sources of informa-
tion about clinical research
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research before and after the‘Get Randomised’campaign
wasmeasuredbyconductingsurveyswithmembersofthe
public.The surveys (Survey 1 before the campaign;Survey
2 6 months after the start of the campaign) were con-
ducted by mruk research (Manchester, UK) as part of a
monthly Scottish Consumer Omnibus Survey. Two thou-
sand and eighty people took part in the surveys (1040
different people at each survey).This sample size allowed
proportionstobeestimatedwithinamarginoferrorof3%.
The structured sample was representative of the adult
Scottish population in gender and age distribution
(Table 1) and geographical spread. Participants were not
asked whether they had any personal health problems as
part of the survey,but the health of the survey population
was likely to be representative of that of the adult Scottish
population.Interviews were conducted between 8 and 14
August 2008 (Survey 1) and between 16 and 22 January
2009 (Survey 2). The questions included in the pre- and
post-campaign surveys are listed in Table 2.
Data are reported as percentages with 95% conﬁdence
intervals(CI)whereappropriate.Differencesinproportions
were analysed using c
2 tests.
Results
There was an improvement in public awareness of clinical
trials following the campaign. The phrase ‘randomised
clinical trial’had been heard of by 37.8% of people (95% CI
34.8,40.7)inthesecondsurveycomparedwith28.6%(95%
CI 25.8, 31.3) in the ﬁrst survey (difference = 9.2%; 95% CI
for difference 5.2, 13.3, P < 0.01).The increased awareness
was across both genders and all age groups (Figures 5
and 6).
Knowledge of aspects of RCTs such as the fact that‘all
agegroupsareneededtotakepartinclinicaltrials’and‘we
all need treatment at some point and trials tell us about
the best treatments’increased from 4.7% (95% CI 2.3, 7.1)
and 2.4% (95% CI 0.6,4.1) in the ﬁrst survey to 16.5% (95%
CI 12.9, 20.2) and 8.4% (95% CI 5.6, 11.1) in the second
survey,respectively (P < 0.01) (Table 3).
Over half of people of both sexes and of all age groups
in the second survey recalled seeing or hearing any adver-
tising recently about RCTs [56.7% (95% CI 51.8,61.6)],com-
pared with 14.8% (95% CI 10.8, 18.9; difference = 41.4%;
95% CI for difference 35.6,48.3;P < 0.01) in the ﬁrst survey.
When asked where they recalled seeing or hearing such
advertising, the most commonly reported media source
was television (91%) followed by newspaper (8%) and
radio (8%). Other places they reported seeing advertising
about RCTs included posters (4%) and magazines
(1%). These ﬁgures may have included other sources of
advertising regarding clinical trials apart from the ‘Get
Randomised’campaign.
When asked to describe the activity or publicity they
saw, 48% described health professionals speaking about
medical research, 28% described health professionals
asking the public to take part in medical research and 17%
described patients speaking about medical research.
Sixteen percent mentioned medical research or clinical
trials in a less speciﬁc manner, 15% described the ‘Get
Randomised’ message and 13% mentioned that the
best evidence comes from RCTs.Eleven percent could not
recall the content of the advertising they had seen or
heard.
Forty-nine percent of respondents described the main
message of the publicity as‘people should take part more
in medical research’. Other main messages reported
included ‘doctors need to do research called randomised
clinical trials’ (27%),‘more medical research is needed all
the time’(24%),‘Get Randomised’(14%),‘the best medical
research is called a randomised clinical trial’ (12%). One
percent reported that the advertisement was too short
and they did not understand it, while 8% gave other
answers.
Participants were asked to what extent they agreed
with a series of statements regarding whether the adver-
tising had made them think or behave differently regard-
ing clinical trials and whether it had improved their
understanding of clinical trials (Q4 in Survey 1 and Q7 in
Survey 2). The proportion of people who disagreed a lot
with these statements decreased from a range of 9.1–
20.5% in the ﬁrst survey to 1.3–4.9% in the second survey.
Table 1
Population distribution by age and gender in the two surveys
Age group (years)
Survey 1 Survey 2
Male Female Total Male Female Total
n (%) n (%) n (%) n (%) n (%) n (%)
16–24 81 (15.9) 96 (18.1) 177 (17.0) 70 (13.5) 77 (14.8) 147 (14.1)
25–34 92 (18.0) 77 (14.5) 169 (16.3) 91 (17.5) 87 (16.7) 178 (17.1)
35–44 94 (18.4) 101 (19.1) 195 (18.8) 107 (20.6) 89 (17.1) 196 (18.8)
45–54 83 (16.3) 82 (15.5) 165 (15.9) 92 (17.7) 86 (16.5) 178 (17.1)
55–64 67 (13.1) 82 (15.5) 149 (14.3) 54 (10.4) 79 (15.2) 133 (12.8)
65+ 93 (18.2) 92 (17.4) 185 (17.8) 106 (20.4) 102 (19.6) 208 (20.0)
Total 510 (100.0) 530 (100.0) 1040 (100.0) 520 (100.0) 520 (100.0) 1040 (100.0)
Impact of‘Get Randomised’campaign
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clinical trial if asked,there was little difference in response
followingthecampaign[‘yes’response31.3%(95%CI28.4,
34.1) vs.30.4% (95% CI 27.6,33.2),difference =- 0.9%;95%
CI for difference -4.8, 3.1%; P = 0.92]. This nonsigniﬁcant
differencewasseeninbothmenandwomenandinallage
groups.
When examples of the ‘Get Randomised’ advertising
were shown or played to them, 29% of people recalled
seeing the television advertisement (10% unsure), 20%
hearing the radio advertisement (14% unsure) and 19%
seeing the newspaper advertisement (15% unsure).
Some people had seen more than one format of the
advertisement.
Table 2
Questions included in the pre- and post-campaign surveys
Pre-campaign survey (Survey 1)
Q1: Have you heard of the phrase ‘randomised clinical trials’?
Yes (go to Q2), No, Don’t know (go to Q3)
Q2: If yes, what does it mean?
Q3: Have you seen or heard any advertising recently about randomised clinical trials?
Yes (go to Q4), No, Don’t know (go to Q5)
Q4: SHOWCARD – ‘I’m now going to show you a list of statements and I’d like you to tell me to what extent you agree or disagree with each’
A – The advertising which I saw or heard made me think or behave differently about taking part in clinical trials in the future
B – The advertising which I saw or heard made me think differently about the importance of clinical trials
C – The advertising which I saw or heard gave me a better understanding of what a randomised clinical trial is
D – The advertising which I saw or heard made me more likely to take part in clinical trials in the future
(Agree a lot; Agree a little; Neither agree nor disagree; Disagree a little; Disagree a lot; Don’t know)
Q5: SHOWCARD – ‘I’m now going to show you a list of statements and I’d like you to tell me to what extent you agree or disagree with each’
A – It is important for everyone to take part in a randomised clinical trial if they are asked
B – Taking part in clinical trials is as valuable to the NHS as giving blood
C – I would take part in a randomised clinical trial if I was asked
D – Taking part in clinical trials is only important if you are ill yourself
E – I would recommend taking part in clinical trials to my friends and family if they asked me what I thought
F–Ia minterested in ﬁnding out more about taking part in clinical trials
(Agree a lot; Agree a little; Neither agree nor disagree; Disagree a little; Disagree a lot; Don’t know)
Post-campaign survey (Survey 2)
Q1: Have you heard of the phrase ‘randomised clinical trials’?
Yes (go to Q2), No, Don’t know (go to Q8)
Q2: If yes, what does it mean?
Q3: Have you seen or heard any advertising recently about randomised clinical trials?
Yes (go to Q4), No, Don’t know (go to Q8)
Q4: Where did you see it or hear it?
Q5: Please describe the activity or publicity you saw/heard concerning randomised clinical trials. What did it show/what did it say? (more than one response
allowed)
Q6: What was the main message(s) of this activity/publicity? (more than one response allowed)
Q7: SHOWCARD – ‘I’m now going to show you a list of statements and I’d like you to tell me to what extent you agree or disagree with each’
A – The advertising which I saw or heard made me think or behave differently about taking part in clinical trials in the future
B – The advertising which I saw or heard made me think differently about the importance of clinical trials
C – The advertising which I saw or heard gave me a better understanding of what a randomised clinical trial is
D – The advertising which I saw or heard made me more likely to take part in clinical trials in the future
(Agree a lot; Agree a little; Neither agree nor disagree; Disagree a little; Disagree a lot; Don’t know)
Q8: SHOWCARD – ‘I’m now going to show you a list of statements and I’d like you to tell me to what extent you agree or disagree with each’
A – It is important for everyone to take part in a randomised clinical trial if they are asked
B – Taking part in clinical trials is as valuable to the NHS as giving blood
C – I would take part in a randomised clinical trial if I was asked
D – Taking part in clinical trials is only important if you are ill yourself
E – I would recommend taking part in clinical trials to my friends and family if they asked me what I thought
F–Ia minterested in ﬁnding out more about taking part in clinical trials
(Agree a lot; Agree a little; Neither agree nor disagree; Disagree a little; Disagree a lot; Don’t know)
Q9: SHOW TV ADVERT. Do you remember seeing this TV advert recently?
Yes, No, Unsure, Refused
Q10: PLAY RADIO ADVERT. Do you remember hearing this advert recently?
Yes, No, Unsure, Refused
Q11: SHOW PRESS IMAGE. Do you remember seeing this advert recently?
Yes, No, Unsure, Refused
Q12: The advertising which I saw or heard made me more likely to take part in clinical trials in the future
Yes, No, Unsure
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agreed with the following statement: ‘I would be more
likely to participate in a clinical trial following this cam-
paign’. The responses were 25% ‘yes’, 48% ‘no’ and 27%
‘unsure’.
Discussion
The ‘Get Randomised’ campaign used a media-based
approach to aim to increase public awareness and under-
standing of clinical research, ultimately improving public
engagement in clinical research.Although the media have
frequently been used to attract volunteers to speciﬁc
studies,tothebestofourknowledgeagenericmediacam-
paign promoting the importance of clinical research has
not previously been run in Scotland. It was hoped that a
media-based campaign using different delivery methods
would reach a large proportion of the population.
Thecampaigndidindeedappeartoraisepublicaware-
ness of clinical trials (we observed an absolute increase in
knowledge of the term of approximately 40% from before
the campaign). This correlates well with the ﬁndings of
previous mass media campaigns reported in the literature.
For example, the Cochrane review of the impact of mass-
mediacampaignsonhealthcareutilizationreportedacon-
sistentimprovementinoutcomesfollowingcampaigns[4].
Making comparisons with the commercial advertising
industry, a campaign of this magnitude with relatively
short advertisements and a comparatively limited budget
may raise brand awareness but would not necessarily be
expected to change consumer behaviour. Commercial
advertising works over an extended period of time to raise
brand awareness and build reputation.Consumers tend to
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chase, once the brand is already in their consciousness
and trusted. Therefore, it may require further efforts
before messages to the public regarding the importance
ofclinicaltrialsresultinincreasedparticipationinresearch.
‘Get Randomised’ was chosen to be the central
message of the campaign. RCTs are widely regarded as
being the gold-standard method of assessing differences
between treatment options. Most clinical research in the
UKisconductedonan‘opt-in’basisratherthanan‘opt-out’
basis, largely due to ethical considerations. An ‘opt-in’
approach often selects out a healthier than average study
population who take more interest in their health in
general and are therefore more likely to volunteer to take
part in research. Unfortunately, this can result in recruit-
ment of a nonrepresentative population to many research
studies [5]. This could be particularly important in some
types of research where end-points are outcomes such as
cardiovascular disease or smoking-related disease, which
are known to correlate with illness behaviours and social
deprivation status.Conversely,in other situations patients
with particular diseases or those who feel that they may
beneﬁtfromaneworexpensivedrugthatisnototherwise
available outside the clinical trial setting may be more
likely to participate in clinical trials. Indeed, organizations
such as the European Platform for Patients’ Organizations,
Science and Industry (http://www.epposi.org) support
patient participation in clinical trials and have expressed
concern at recent meetings that the European Clinical
Trials Directive may adversely affect entry into clinical
trials. UK researchers have also expressed concern that
increased bureaucracy has made clinical trials more
administratively cumbersome and expensive [6]. It is
important to encourage all sectors of society to under-
standmoreaboutclinicalresearchandtofeelthattheyare
able to take part in it. Using the media may help to bring
the message that clinical research is important to sectors
of the population who are more difﬁcult to reach by
standard methods such as lengthy invitation letters and
information sheets for individual studies.
In most research studies,invitations to patients to par-
ticipate result in a signiﬁcant nonresponse rate. In our
experience this varies, but is often around 50% and is
accompaniedbyarefusalrateofanother25%,leavingonly
25% of the original population approached potentially
willing to be recruited to the study. On further screening,
some of the patients initially selected may be excluded for
other reasons, resulting in a much diminished population
who actually enter the treatment arm of a study [in our
recent experience in recruiting to a large RCT only 14% of
the originally identiﬁed suitable population are eventually
randomised to therapy (clinicaltrials.gov – NCT00447759)].
Some trials experience even lower response rates.
Successfulrecruitmenttoclinicalresearchstudiesrelies
heavily on improving the proportion of patients initially
responding positively to an invitation to participate.
Despite this, the reasons for nonresponse and refusal are
still poorly understood. Some of the factors leading to
patients failing to respond or refusing to take part in
research may include failure to receive or understand the
letter or information sheet,failure to feel that the research
appliestothemasindividuals,feelingsthattheywouldnot
beofinteresttotheresearchers,apathy,lackoftimedueto
other commitments and feelings of invasion of privacy [7].
More speciﬁcally, in RCTs, some people fail to understand
the concept of randomisation [8] and may prefer treat-
ment to be allocated by conscious decision as occurs in
normal care. There is some, albeit limited, evidence that
patients who participate in clinical trials may have better
outcomes[9],andinotherrecentmeta-analysesthereisno
evidence of a harmful effect of participating in clinical
trials and if anything there is a trend towards beneﬁt
Table 3
Understanding of randomised clinical trials
Statement
Survey 1
August
2008 %
Survey 2
January
2009 %
Difference
(95% CI) % P-value
Clinical trials are needed to ﬁnd out what treatments work 21.5 33.1 11.6 (4.9, 18.1) <0.01
Clinical trials are needed to make medical progress 28.6 26.0 -2.6 (-9.4, 4.1) 0.44
Doctors decide on treatments based on the results of clinical trials 19.5 22.1 2.6 (-3.5, 8.7) 0.41
Taking part in clinical trials helps other people 11.4 24.4 13.0 (7.4, 18.6) <0.01
Randomised clinical trials allocate treatments to participants by chance 18.5 17.6 -0.9 (-6.8, 4.8) 0.75
All age groups are needed to take part in clinical trials 4.7 16.5 11.8 (7.4, 16.2) <0.01
Randomised clinical trials are required to study older treatments as well as
newer treatments
5.7 13.7 8.0 (3.7, 12.3) <0.01
To improve the health service we need information from clinical trials 9.8 13.5 3.7 (-1.1, 8.5) 0.14
Patients who take part in clinical trials generally have a good outcome 2.4 8.9 6.5 (3.2, 9.9) <0.01
We all need treatment at some point and trials tell us about the best treatments 2.4 8.4 6.0 (2.8, 9.3) <0.01
Don’t know 7.1 13.0 5.9 (1.5, 10.3) 0.01
Patients were asked what ‘randomised clinical trials’ meant (Q2). Figures are percentages of respondents who expressed these statements. 95% conﬁdence intervals are given for
the differences in response between the two surveys.
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increase recruitment into clinical trials are successful and
further investigation into this area is needed [12,13].
Conclusions
Public awareness and understanding of clinical research is
key to ensuring adequate recruitment to clinical research
trials. This media-based campaign was successful in its
primaryaimofraisingpublicawarenessofclinicalresearch
in Scotland. Although the post-campaign survey revealed
an increase in understanding of some aspects of clinical
trials, there was no apparent signiﬁcant increase in the
individual willingness of members of the public to partici-
pate in clinical research studies. Therefore, the campaign
may have been better at raising public awareness of
research than convincing the public to participate person-
ally in research trials.However,this might be the ﬁrst stage
in increasing public participation in clinical trials.Whether
the campaign will increase public participation in clinical
research in the long term will require further evaluation.
Perhaps a concerted national effort is needed to improve
public engagement and continue to raise awareness of
the importance of clinical research.
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